HEADER ISOMERASE 15-NOV-13 4NML TITLE 2.60 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF PUTATIVE RIBOSE 5- TITLE 2 PHOSPHATE ISOMERASE FROM TOXOPLASMA GONDII ME49 IN COMPLEX WITH DL- TITLE 3 MALIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBULOSE 5-PHOSPHATE ISOMERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 5.3.1.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 508771; SOURCE 4 STRAIN: ME49; SOURCE 5 GENE: TGME49_239310; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) MAGIC; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG28 KEYWDS CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, NIAID, KEYWDS 2 NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.S.HALAVATY,I.DUBROVSKA,K.FLORES,D.SHANMUGAM,L.SHUVALOVA,D.ROOS, AUTHOR 2 J.RUAN,H.NGO,W.F.ANDERSON,CENTER FOR STRUCTURAL GENOMICS OF AUTHOR 3 INFECTIOUS DISEASES (CSGID) REVDAT 4 27-JAN-21 4NML 1 JRNL REMARK SEQADV LINK REVDAT 3 22-NOV-17 4NML 1 REMARK REVDAT 2 22-JAN-14 4NML 1 AUTHOR JRNL REVDAT 1 04-DEC-13 4NML 0 JRNL AUTH J.D.LYKINS,E.V.FILIPPOVA,A.S.HALAVATY,G.MINASOV,Y.ZHOU, JRNL AUTH 2 I.DUBROVSKA,K.J.FLORES,L.A.SHUVALOVA,J.RUAN,K.EL BISSATI, JRNL AUTH 3 S.DOVGIN,C.W.ROBERTS,S.WOODS,J.D.MOULTON,H.MOULTON, JRNL AUTH 4 M.J.MCPHILLIE,S.P.MUENCH,C.W.G.FISHWICK,E.SABINI, JRNL AUTH 5 D.SHANMUGAM,D.S.ROOS,R.MCLEOD,W.F.ANDERSON,H.M.NGO JRNL TITL CSGID SOLVES STRUCTURES AND IDENTIFIES PHENOTYPES FOR FIVE JRNL TITL 2 ENZYMES IN TOXOPLASMA GONDII . JRNL REF FRONT CELL INFECT MICROBIOL V. 8 352 2018 JRNL REFN ESSN 2235-2988 JRNL PMID 30345257 JRNL DOI 10.3389/FCIMB.2018.00352 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 15802 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 842 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1134 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.83 REMARK 3 BIN R VALUE (WORKING SET) : 0.2580 REMARK 3 BIN FREE R VALUE SET COUNT : 63 REMARK 3 BIN FREE R VALUE : 0.3440 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1866 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 11 REMARK 3 SOLVENT ATOMS : 71 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.90000 REMARK 3 B22 (A**2) : 0.90000 REMARK 3 B33 (A**2) : -1.79000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.219 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.192 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.125 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.556 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1938 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1909 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2619 ; 1.711 ; 2.001 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4403 ; 0.810 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 256 ; 3.346 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 76 ;33.521 ;23.947 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 326 ;13.183 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;17.819 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 308 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2197 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 400 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 130 REMARK 3 ORIGIN FOR THE GROUP (A): 17.0838 58.1989 7.1733 REMARK 3 T TENSOR REMARK 3 T11: 0.1656 T22: 0.4204 REMARK 3 T33: 0.1527 T12: -0.1361 REMARK 3 T13: -0.0219 T23: -0.0969 REMARK 3 L TENSOR REMARK 3 L11: 1.7728 L22: 1.4500 REMARK 3 L33: 3.9358 L12: 0.6736 REMARK 3 L13: 0.0743 L23: -0.9530 REMARK 3 S TENSOR REMARK 3 S11: -0.1224 S12: 0.3365 S13: 0.0618 REMARK 3 S21: -0.0526 S22: 0.1028 S23: -0.0303 REMARK 3 S31: -0.6467 S32: 0.3229 S33: 0.0196 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 131 A 257 REMARK 3 ORIGIN FOR THE GROUP (A): 11.6622 40.4088 16.7612 REMARK 3 T TENSOR REMARK 3 T11: 0.1506 T22: 0.2808 REMARK 3 T33: 0.1814 T12: -0.0416 REMARK 3 T13: -0.0058 T23: -0.1397 REMARK 3 L TENSOR REMARK 3 L11: 1.4060 L22: 0.9604 REMARK 3 L33: 6.8607 L12: -0.1001 REMARK 3 L13: 0.0052 L23: -0.6066 REMARK 3 S TENSOR REMARK 3 S11: -0.1317 S12: 0.1959 S13: -0.2220 REMARK 3 S21: -0.1704 S22: 0.1333 S23: 0.1732 REMARK 3 S31: 0.9195 S32: -0.0096 S33: -0.0016 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4NML COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1000083391. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : DIAMOND(111) REMARK 200 OPTICS : BE LENSES REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16774 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 14.20 REMARK 200 R MERGE (I) : 0.09400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 44.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 14.70 REMARK 200 R MERGE FOR SHELL (I) : 0.61600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: HKL-3000 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 71.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 7.1 MG/ML IN 10 MM TRIS-HCL REMARK 280 PH 8.3 500 MM NACL 5 MM BME, CRYSTALLIZATION THE JCSG+ SUITE (F8 REMARK 280 OR #68): 2.1 M DL-MALIC ACID PH 7.0, CRYO 1:1 (V/V) 50% SUCROSE REMARK 280 AND F8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.34700 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.17350 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 84.52050 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 56.34700 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 84.52050 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 28.17350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -61.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 95.59000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 56.34700 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 430 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 447 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 GLU A 182 REMARK 465 LYS A 183 REMARK 465 ASN A 184 REMARK 465 GLY A 185 REMARK 465 GLY A 186 REMARK 465 ARG A 258 REMARK 465 LYS A 259 REMARK 465 GLY A 260 REMARK 465 GLU A 261 REMARK 465 ASN A 262 REMARK 465 LEU A 263 REMARK 465 TYR A 264 REMARK 465 PHE A 265 REMARK 465 GLN A 266 REMARK 465 SER A 267 REMARK 465 ALA A 268 REMARK 465 GLY A 269 REMARK 465 HIS A 270 REMARK 465 HIS A 271 REMARK 465 HIS A 272 REMARK 465 HIS A 273 REMARK 465 HIS A 274 REMARK 465 HIS A 275 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 81 -136.91 -94.81 REMARK 500 ASN A 133 -22.38 67.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MLT A 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: CSGID-IDP92040 RELATED DB: TARGETTRACK DBREF 4NML A 1 259 UNP S8GQK2 S8GQK2_TOXGO 1 259 SEQADV 4NML GLY A 260 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML GLU A 261 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML ASN A 262 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML LEU A 263 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML TYR A 264 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML PHE A 265 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML GLN A 266 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML SER A 267 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML ALA A 268 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML GLY A 269 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML HIS A 270 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML HIS A 271 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML HIS A 272 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML HIS A 273 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML HIS A 274 UNP S8GQK2 EXPRESSION TAG SEQADV 4NML HIS A 275 UNP S8GQK2 EXPRESSION TAG SEQRES 1 A 275 MSE ASN PRO GLN ASP LYS ALA LYS GLN ALA VAL GLY TYR SEQRES 2 A 275 PHE ALA VAL ASP THR TYR VAL ARG SER GLY MSE LYS VAL SEQRES 3 A 275 GLY LEU GLY THR GLY THR THR ALA LYS PHE VAL VAL GLU SEQRES 4 A 275 ARG ILE GLY GLN ARG MSE GLN GLU GLY SER LEU LYS ASP SEQRES 5 A 275 LEU LEU CYS VAL PRO THR SER GLU ALA THR ARG LYS GLN SEQRES 6 A 275 ALA GLU SER LEU GLY ILE PRO LEU THR THR LEU ASP GLY SEQRES 7 A 275 ILE ALA ASP CME LEU ASP VAL ALA ILE ASP GLY ALA ASP SEQRES 8 A 275 GLU ILE LEU PRO PRO THR LEU GLY LEU VAL LYS GLY ARG SEQRES 9 A 275 GLY GLY ALA LEU LEU ARG GLU LYS MSE ILE ALA ALA ALA SEQRES 10 A 275 ALA LYS THR PHE ILE VAL ALA ALA ASP GLU THR LYS LEU SEQRES 11 A 275 VAL SER ASN GLY ILE GLY SER THR GLY ALA LEU PRO VAL SEQRES 12 A 275 GLU VAL VAL VAL PHE SER GLY SER HIS THR LYS ARG LEU SEQRES 13 A 275 LEU SER ALA LEU PRO SER VAL LYS ARG HIS GLY GLY ARG SEQRES 14 A 275 ALA GLU PHE ARG LYS ARG ALA GLY ALA ALA THR GLY GLU SEQRES 15 A 275 LYS ASN GLY GLY GLN GLU ASP ILE ARG GLU GLU ASP ARG SEQRES 16 A 275 PHE VAL THR ASP ASN GLY ASN TYR ILE VAL ASP LEU TYR SEQRES 17 A 275 PHE THR GLU THR VAL PRO ASP LEU HIS GLU MSE ASP LYS SEQRES 18 A 275 GLU LEU LYS SER ILE PRO GLY VAL VAL GLU THR GLY PHE SEQRES 19 A 275 PHE LEU ASP LEU ALA SER VAL CYS LEU ILE GLY LYS ALA SEQRES 20 A 275 ASP GLY SER VAL ALA THR LEU THR ALA GLU ARG LYS GLY SEQRES 21 A 275 GLU ASN LEU TYR PHE GLN SER ALA GLY HIS HIS HIS HIS SEQRES 22 A 275 HIS HIS MODRES 4NML MSE A 1 MET SELENOMETHIONINE MODRES 4NML MSE A 24 MET SELENOMETHIONINE MODRES 4NML MSE A 45 MET SELENOMETHIONINE MODRES 4NML CME A 82 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4NML MSE A 113 MET SELENOMETHIONINE MODRES 4NML MSE A 219 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 24 8 HET MSE A 45 8 HET CME A 82 10 HET MSE A 113 8 HET MSE A 219 8 HET CL A 301 1 HET CL A 302 1 HET MLT A 303 9 HETNAM MSE SELENOMETHIONINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM CL CHLORIDE ION HETNAM MLT D-MALATE HETSYN MLT (2R)-2-HYDROXYBUTANEDIOIC ACID; 2-HYDROXY-SUCCINIC ACID FORMUL 1 MSE 5(C5 H11 N O2 SE) FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 CL 2(CL 1-) FORMUL 4 MLT C4 H6 O5 FORMUL 5 HOH *71(H2 O) HELIX 1 1 ASN A 2 VAL A 20 1 19 HELIX 2 2 GLY A 31 GLU A 47 1 17 HELIX 3 3 SER A 59 SER A 68 1 10 HELIX 4 4 THR A 75 ILE A 79 5 5 HELIX 5 5 ALA A 107 ALA A 117 1 11 HELIX 6 6 THR A 128 LEU A 130 5 3 HELIX 7 7 SER A 149 LEU A 160 1 12 HELIX 8 8 LEU A 160 HIS A 166 1 7 HELIX 9 9 ARG A 191 ARG A 195 5 5 HELIX 10 10 ASP A 215 SER A 225 1 11 SHEET 1 A 6 LEU A 54 PRO A 57 0 SHEET 2 A 6 LYS A 25 LEU A 28 1 N VAL A 26 O LEU A 54 SHEET 3 A 6 LEU A 83 ASP A 88 1 O VAL A 85 N GLY A 27 SHEET 4 A 6 ALA A 118 ASP A 126 1 O ILE A 122 N ALA A 86 SHEET 5 A 6 VAL A 241 GLY A 245 1 O LEU A 243 N VAL A 123 SHEET 6 A 6 VAL A 251 THR A 255 -1 O LEU A 254 N CYS A 242 SHEET 1 B 3 GLU A 92 LEU A 94 0 SHEET 2 B 3 GLY A 99 VAL A 101 -1 O GLY A 99 N LEU A 94 SHEET 3 B 3 PHE A 234 PHE A 235 -1 O PHE A 235 N LEU A 100 SHEET 1 C 4 ARG A 169 PHE A 172 0 SHEET 2 C 4 TYR A 203 TYR A 208 -1 O ASP A 206 N GLU A 171 SHEET 3 C 4 LEU A 141 VAL A 145 -1 N VAL A 143 O VAL A 205 SHEET 4 C 4 VAL A 229 THR A 232 -1 O GLU A 231 N GLU A 144 LINK C MSE A 1 N ASN A 2 1555 1555 1.33 LINK C GLY A 23 N MSE A 24 1555 1555 1.32 LINK C MSE A 24 N LYS A 25 1555 1555 1.33 LINK C ARG A 44 N MSE A 45 1555 1555 1.33 LINK C MSE A 45 N GLN A 46 1555 1555 1.33 LINK C ASP A 81 N CME A 82 1555 1555 1.32 LINK C CME A 82 N LEU A 83 1555 1555 1.31 LINK C LYS A 112 N MSE A 113 1555 1555 1.32 LINK C MSE A 113 N ILE A 114 1555 1555 1.33 LINK C GLU A 218 N MSE A 219 1555 1555 1.34 LINK C MSE A 219 N ASP A 220 1555 1555 1.33 CISPEP 1 PRO A 95 PRO A 96 0 4.38 SITE 1 AC1 5 GLY A 103 GLY A 105 GLY A 106 ALA A 107 SITE 2 AC1 5 GLU A 111 SITE 1 AC2 4 LYS A 154 PHE A 172 ASP A 189 ILE A 190 SITE 1 AC3 9 LYS A 8 THR A 32 THR A 33 GLY A 89 SITE 2 AC3 9 ALA A 90 ASP A 91 LYS A 129 HOH A 408 SITE 3 AC3 9 HOH A 416 CRYST1 95.590 95.590 112.694 90.00 90.00 90.00 P 41 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010461 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010461 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008874 0.00000 HETATM 1 N MSE A 1 24.550 48.851 -10.485 1.00101.97 N ANISOU 1 N MSE A 1 11103 17381 10258 -1753 1278 -2451 N HETATM 2 CA MSE A 1 23.958 48.213 -9.265 1.00 98.47 C ANISOU 2 CA MSE A 1 10702 16643 10069 -1586 1191 -2474 C HETATM 3 C MSE A 1 22.775 47.378 -9.692 1.00 91.73 C ANISOU 3 C MSE A 1 10054 15605 9193 -1581 1141 -2607 C HETATM 4 O MSE A 1 22.202 47.605 -10.758 1.00 87.02 O ANISOU 4 O MSE A 1 9571 15087 8404 -1746 1112 -2622 O HETATM 5 CB MSE A 1 23.585 49.266 -8.216 1.00 99.77 C ANISOU 5 CB MSE A 1 10839 16691 10375 -1664 1018 -2259 C HETATM 6 CG MSE A 1 23.092 50.595 -8.804 1.00100.37 C ANISOU 6 CG MSE A 1 10985 16838 10311 -1908 902 -2088 C HETATM 7 SE MSE A 1 22.473 51.792 -7.355 1.00102.91 SE ANISOU 7 SE MSE A 1 11335 16935 10831 -1950 694 -1853 SE HETATM 8 CE MSE A 1 24.164 51.891 -6.333 1.00 98.19 C ANISOU 8 CE MSE A 1 10506 16466 10333 -1877 791 -1817 C